11-822820-C-CTCT
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BA1
The NM_020376.4(PNPLA2):c.696+215_696+216insCTT variant causes a intron change involving the alteration of a non-conserved nucleotide. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.39 ( 12903 hom., cov: 0)
Consequence
PNPLA2
NM_020376.4 intron
NM_020376.4 intron
Scores
Not classified
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 1.77
Publications
2 publications found
Genes affected
PNPLA2 (HGNC:30802): (patatin like phospholipase domain containing 2) This gene encodes an enzyme which catalyzes the first step in the hydrolysis of triglycerides in adipose tissue. Mutations in this gene are associated with neutral lipid storage disease with myopathy. [provided by RefSeq, Jul 2010]
PNPLA2 Gene-Disease associations (from GenCC):
- neutral lipid storage myopathyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, ClinGen, G2P, Labcorp Genetics (formerly Invitae), Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -8 ACMG points.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.535 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| PNPLA2 | NM_020376.4 | c.696+215_696+216insCTT | intron_variant | Intron 5 of 9 | ENST00000336615.9 | NP_065109.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| PNPLA2 | ENST00000336615.9 | c.696+214_696+215insTCT | intron_variant | Intron 5 of 9 | 1 | NM_020376.4 | ENSP00000337701.4 | |||
| PNPLA2 | ENST00000525250.5 | n.1302+214_1302+215insTCT | intron_variant | Intron 3 of 5 | 2 | |||||
| PNPLA2 | ENST00000531923.1 | n.591+214_591+215insTCT | intron_variant | Intron 1 of 1 | 2 | |||||
| ENSG00000255108 | ENST00000532946.2 | n.*214_*215insAGA | downstream_gene_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.394 AC: 51935AN: 131654Hom.: 12903 Cov.: 0 show subpopulations
GnomAD3 genomes
AF:
AC:
51935
AN:
131654
Hom.:
Cov.:
0
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.394 AC: 51922AN: 131628Hom.: 12903 Cov.: 0 AF XY: 0.383 AC XY: 23821AN XY: 62172 show subpopulations
GnomAD4 genome
AF:
AC:
51922
AN:
131628
Hom.:
Cov.:
0
AF XY:
AC XY:
23821
AN XY:
62172
show subpopulations
African (AFR)
AF:
AC:
4422
AN:
36410
American (AMR)
AF:
AC:
6651
AN:
12596
Ashkenazi Jewish (ASJ)
AF:
AC:
1348
AN:
3284
East Asian (EAS)
AF:
AC:
1097
AN:
4656
South Asian (SAS)
AF:
AC:
854
AN:
4278
European-Finnish (FIN)
AF:
AC:
2425
AN:
4962
Middle Eastern (MID)
AF:
AC:
90
AN:
238
European-Non Finnish (NFE)
AF:
AC:
33771
AN:
62582
Other (OTH)
AF:
AC:
732
AN:
1770
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
1116
2232
3349
4465
5581
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
464
928
1392
1856
2320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.